|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1999-4-30
|
|
pubmed:abstractText |
Multidrug-resistant tuberculosis patients without human immunodeficiency virus (HIV) infection, with Mycobacterium tuberculosis resistant to almost all of the available drugs.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1027-3719
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
214-8
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10094322-Adult,
pubmed-meshheading:10094322-Chronic Disease,
pubmed-meshheading:10094322-Female,
pubmed-meshheading:10094322-Follow-Up Studies,
pubmed-meshheading:10094322-Humans,
pubmed-meshheading:10094322-Interferon-alpha,
pubmed-meshheading:10094322-Male,
pubmed-meshheading:10094322-Middle Aged,
pubmed-meshheading:10094322-Prospective Studies,
pubmed-meshheading:10094322-Recombinant Proteins,
pubmed-meshheading:10094322-Treatment Outcome,
pubmed-meshheading:10094322-Tuberculosis, Multidrug-Resistant,
pubmed-meshheading:10094322-Tuberculosis, Pulmonary
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Phase II trial of recombinant interferon-alpha2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up.
|
|
pubmed:affiliation |
Institute of Pulmonary Diseases, University of Buenos Aires, Argentina.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
